Journal Mobile Options
Table of Contents
Vol. 30, No. 3, 2008
Issue release date: May 2008
Section title: Original Paper
Free Access
Neuroepidemiology 2008;30:174–179
(DOI:10.1159/000126909)

Fasting Insulin Levels and Cognitive Decline in Older Women without Diabetes

van Oijen M.a · Okereke O.I.b, c · Kang J.H.c · Pollak M.N.f · Hu F.B.c, e · Hankinson S.E.c, d · Grodstein F.b-d
aDepartments of Epidemiology/Biostatistics and Neurology, Erasmus Medical Center, Rotterdam, The Netherlands; bDivision of Aging and cChanning Laboratory, Department of Medicine, Brigham and Women’s Hospital, and Harvard Medical School, dDepartments of Epidemiology and eNutrition, Harvard School of Public Health, Boston, Mass., USA; fDepartments of Medicine and Oncology, Lady Davis Research Institute of the Jewish General Hospital and McGill University, Montreal, Que., Canada
email Corresponding Author

Dr. Francine Grodstein

Channing Laboratory, Department of Medicine

Brigham and Women’s Hospital, Harvard Medical School, 181 Longwood Avenue

Boston, MA 02115 (USA)

Tel. +1 617 525 2279, Fax +1 617 525 2008, E-Mail fgrodstein@partners.org


References

  1. Ott A, Stolk RP, van Harskamp F, Pols HA, Hofman A, Breteler MM: Diabetes mellitus and the risk of dementia. The Rotterdam Study. Neurology 1999;53:1937–1942.
  2. Coker LH, Shumaker SA: Type 2 diabetes mellitus and cognition: an understudied issue in women’s health. J Psychosom Res 2003;54:129–139.
  3. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, Cummings SR: Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000;160:174–180.
  4. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P: Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64–74.
  5. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S: Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003;100:4162–4167.
  6. Luchsinger JA, Tang MX, Shea S, Mayeux R: Hyperinsulinemia and risk of Alzheimer disease. Neurology 2004;63:1187–1192.
  7. Peila R, Rodriguez BL, White LR, Launer LJ: Fasting insulin and incident dementia in an elderly population of Japanese-American men. Neurology 2004;63:228–233.
  8. Okereke O, Hankinson SE, Hu FB, Grodstein F: Plasma C peptide level and cognitive function among older women without diabetes mellitus. Arch Intern Med 2005;165:1651–1656.
  9. Brandt J, Spencer M, Folstein MF: The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:111–117.
  10. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  11. Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH: Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer’s disease. Int J Neurosci 1991;57:167–178.
  12. Chen P, Ratcliff G, Belle SH, Cauley JA, DeKosky ST, Ganguli M: Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 2001;58:853–858.
  13. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L: The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol 2000;57:839–844.
  14. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 1982;38:963–974.
  15. Kalmijn S, Feskens EJ, Launer LJ, Stijnen T, Kromhout D: Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia 1995;38:1096–1102.
  16. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K: Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004;63:658–663.
  17. Yaffe K, Blackwell T, Whitmer RA, Krueger K, Barrett Connor E: Glycosylated hemoglobin level and development of mild cognitive impairment or dementia in older women. J Nutr Health Aging 2006;10:293–295.
  18. Okereke O, Kang JH, Gaziano JM, Ma J, Stampfer MJ, Grodstein F: Plasma C-peptide and cognitive performance in older men without diabetes. Am J Geriatr Psychiatry 2006;14:1041–1050.
  19. Biessels GJ, Kappelle LJ: Increased risk of Alzheimer’s disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology? Biochem Soc Trans 2005;33:1041–1044.
  20. Banks WA: The source of cerebral insulin. Eur J Pharmacol 2004;490:5–12.
  21. Park CR: Cognitive effects of insulin in the central nervous system. Neurosci Biobehav Rev 2001;25:311–323.
  22. Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Nathan L, Rifai N, Liu S: Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women’s Health Initiative Observational Study. Diabetes Care 2007;30:1747–1752.
  23. Lawlor DA, Fraser A, Ebrahim S, Smith GD: Independent associations of fasting insulin, glucose, and glycated haemoglobin with stroke and coronary heart disease in older women. PLoS Med 2007;4:e263.